Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- PFIZER INC - Regulatory Approval.
- Pfizer Receives European Approval to Market AromasinR for Adjuvant Treatment of Early Breast Cancer in Postmenopausal Women Aromasin Now the First and Only Hormonal Breast Cancer Drug...
- Research articles 2005-09-13
- PFIZER INC - Research Update.
- New Data On Pfizer's Aromasin and Ellence to Be Presented at San Antonio Breast Cancer Symposium Pfizer Begins...
- Research articles 2006-12-15
- Chiron and Ciba announce FDA market clearance of Aredia® for treatment of patients with Osteolytic Bone Metastases of breast cancer; First Therapeutic For Osteolytic Bone Metastases Associated with Breast Cancer
- EMERYVILLE, Calif. and SUMMIT, N.J.--HealthWire--August 12, 1996-- Chiron Therapeutics, a business unit of Chiron Corporation (Nasdaq: CHIR), and Ciba Pharmaceuticals, a division of Ciba-Geigy Corporation jointly announced today that the United States Food and Drug Administration FDA has cleared ArediaR pamidronate disodium for injection for marketing for the treatment of...
- Research articles 1996-08-12
- Solucient Study: Radiation Therapy Used for Less than Half of Senior Patients Following Key Breast Cancer Procedure
- EVANSTON, Ill., Oct. 24 /U.S. Newswire/ -- Findings released by Solucient confirm a trend verified by medical researchers in recent years -- senior women who undergo breast-conserving surgery, or "lumpectomy", to treat breast cancer often do notEVANSTON, Ill., Oct. 24 /U.S. Newswire/ -- Findings released by Solucient confirm a trend...
- Research articles 2003-10-24
- Bone Scintigraphy and Marker Levels in Breast Cancer
- Begic et al. from the University Clinic Center in Sarajevo Bosnia and Herzegovina reported in the February issue of the Bosnian Journal of Basic Medical Sciences (2005; 5:23-26) on a study designed to correlate levels of the tumor marker Ca 15-3 with inBegic et al. from the University Clinic Center...
- Research articles 2005-05-01
- (99m)Tc-sestamibi imaging in the assessment of toremifene as a modulator of multidrug resistance in patients with breast cancer
- Multidrug resistance MDR due to expression of a membraneassociated permeability glycoprotein (P-glycoprotein [Pgp]) prevents successful cytotoxic chemotherapy for breast cancer. Identification of MDR would facilitate selection of chemotherapy regimens aMultidrug resistance MDR due to expression of a membraneassociated permeability glycoprotein (P-glycoprotein [Pgp]) prevents successful cytotoxic chemotherapy for breast cancer. Identification...
- Research articles 2002-04-01
- FDA Advisory Committee Recommends Approval of First Test to Select Potential Patients for New Biologic Drug for Breast Cancer
- COPENHAGEN, Denmark--BW HealthWire--Sept. 4, 1998--DAKO A/S today announced that HercepTestTM was recommended unanimously for approval by a joint committee of the Hematology and Pathology Devices Panel and Immunology Devices Panel to the U.S. Food and Drug Administration FDA conditional on the company providing clear guidelines on conducting the test.
- Research articles 1998-09-04
- Proven Outcomes in Analog Mammography: Adding Value to Diagnostic Speed and Patient Care
- Breast cancer is one of the most common types of cancer affecting women in the United States, with over 200,000 cases diagnosed and more than 40,000 deaths in 2005. Early detection remains the best tool in the fight against breast cancer. Both screening and diagnostic mammography play key roles in...
- White papers 2006-03-01
Additional Resources
- Lifetime and Millions of Its Viewers Applaud the Re-Introduction of the Bipartisan Breast Cancer Patient Protection Act
- To: HEALTH EDITORSContact: Geralyn Lucas of Lifetime, +1-212-424-7066, or lucas@lifetimetv.com WASHINGTON, Feb. 2 /PRNewswire-USNewswire/ -- U.S. Senators Mary Landrieu (D-LA) and Olympia Snowe (R-ME) together with Congresswoman Rosa L. DeLauro (D-CT) renewed their support for breast cancer patients by reintroducing The Breast Cancer Patient Protection Act. The bipartisan Breast Cancer...
- Research articles 2007-02-02
- Clarient: New Breast-Cancer Test
- Douglas Cress submits: For women who survive breast cancer, the triumph of beating the odds is often tempered by a fear of the cancer returning. A study published last year in the Journal of the National Cancer Institute looked at 3,000 breast cancer patients, and found that the group averaged...
- External links 2009-05-05
- diaDexus Launches Collaboration to Evaluate the Role of Breast Tumor Genes in the Treatment of Breast Cancer
- SOUTH SAN FRANCISCO, Calif. -- diaDexus, Inc., a privately held biotechnology company, announced a collaboration with Mayo Validation Support Services to investigate a test featuring a select panel of tumor-specific genes to aid in patient risk stratification and assist in chemotherapy treatment decisions for breast cancer patients. The test uses...
- Research articles 2007-01-10
- J&B Restaurant Partners to Sponsor "Making Strides Against Breast Cancer" Walk at Jones Beach
- J&B Restaurant Partners (J&B), operators of all Friendly's LI restaurants, has announced that it will serve as a sponsor for the American Cancer Society's "Making Strides Against Breast Cancer" walk on Sunday, October 15 at Jones Beach State Park. The 5-mile walk to raise awareness and dollars to fight...
- Research articles 2006-09-28
- Genetic breast cancer test helps refine treatment plans
- Spokane-based Rockwood Clinic PS is participating in a clinical study of a technique to identify genetic markers in cancerous breast tumors that can help doctors predict whether a cancer patient is at risk for developing metastatic cancer later. Already, Rockwood specialists have altered two patients' treatment plans because of results...
- Research articles 2009-03-26
- Harbor UCLA Medical Center Begins Phase I Clinical Trials of Celsion's Breast Cancer Treatment System; Testing Also Began in October at a Columbia/HCA Member Hospital in Florida
- COLUMBIA, Md.--BW HealthWire--Dec. 7, 1999-- Celsion Corporation (OTC BB:CELN) today announced that Harbor UCLA Medical Center in California is currently recruiting patients for Phase I clinical trials of Celsion's breast cancer treatment system. Additional Phase I testing began in October at a Columbia/HCA member hospital in Florida to expedite...
- Research articles 1999-12-07
- Celsion Receives FDA Approval for Phase I Breast Cancer Ablation Trials At Two New Sites
- COLUMBIA, Md.--BW HealthWire--Aug. 16, 1999-- -- Evaluation to be Accelerated via Studies to be Conducted at UCLA and Columbia FL -- Celsion Corp. (OTC BB:CELN) today announced that it has received approval from the U.S. Food and Drug Administration FDA to commence Phase I clinical studies at...
- Research articles 1999-08-16
- Money Mailer. (Community Outreach).(donates advertisement space for breast cancer research)(Brief Article)
- Money Mailer franchisees in Philadelphia and Southern New Jersey donated ads in a mailing of their envelopes that helped to raise more than $150,000 for the City of Hope's breast cancer research and patient care programs. Money Mailer franchisees in Agoura Hills, Calif. also donated ad...
- Research articles 2003-01-01
- Training of Primary Care Physicians Helps Increase Referrals and Cardiac Rhythm Management Device Sales
- PALO ALTO, Calif. -- The cardiac rhythm management CRM market is poised for phenomenal growth with about 22 million cardiac patients worldwide and more people dying of sudden cardiac arrest than from lung/breast cancer and AIDS combined. The expanding patient pool and increasingly sophisticated technological innovations make it imperative...
- Research articles 2004-10-27
- Mentor Capital: Risk Mitigated Call Option on Cancer Immunotherapy
- Mike Havrilla submits:The stock research section of BioMedReports.com has been updated to include my 8-page report for Mentor Capital (MNTR.PK), which is current as of the 8/28/09 publication date. Highlights from the report that make Mentor’s stock a compelling investment for individuals interested in the small/micro-cap biomed space are outlined...
- External links 2009-08-30
- Aurora Breast MRI Well Poised to Help Meet Increased Demand for Breast MRI Screening of High Risk Patients Per New Guidelines from American Cancer Society
- Only FDA Cleared Breast MRI System Specifically Designed for Breast Imaging Able to Scan Higher Patient Volumes Without Competing for Scan Time on Whole-Body MRI Systems ANDOVER, Mass. -- In response to the American Cancer Society's newly established breast cancer screening guidelines announced yesterday, Aurora Imaging Technology, Inc., manufacturer...
- Research articles 2007-03-29
- 'Why I Wore Lipstick To My Mastectomy'
- During National Breast Cancer Awareness Month singer Patti LaBelle makes a cameo appearance as fellow cancer patient Monisha in this movie based on the memoir of the same name by Geralyn Lucas, a breast cancer survivor and Lifetime TV's director of Public Affairs. Lucas tells her story of her diagnosis...
- Research articles 2006-10-23
- << Previous
- page 1 of 1
- Next >>
